Attached files
| file | filename |
|---|---|
| EX-1.1 - EX-1.1 - HEALTHCARE REALTY TRUST INC | g25757exv1w1.htm |
| EX-8.1 - EX-8.1 - HEALTHCARE REALTY TRUST INC | g25757exv8w1.htm |
| EX-1.2 - EX-1.2 - HEALTHCARE REALTY TRUST INC | g25757exv1w2.htm |
| 8-K - FORM 8-K - HEALTHCARE REALTY TRUST INC | g25757e8vk.htm |
Exhibit 5.1
Waller Lansden Dortch & Davis, LLP
Nashville City Center
511 Union Street, Suite 2700
Nashville, Tennessee 37219-8966
(615) 244-6380
Fax: (615) 244-6804
www.wallerlaw.com
January 11, 2011
Nashville City Center
511 Union Street, Suite 2700
Nashville, Tennessee 37219-8966
(615) 244-6380
Fax: (615) 244-6804
www.wallerlaw.com
January 11, 2011
1901 Sixth Avenue North, Suite 1400
Birmingham, Alabama 35203-2623
(205) 214-6380
Birmingham, Alabama 35203-2623
(205) 214-6380
Healthcare Realty Trust Incorporated
3310 West End Avenue, Suite 700
Nashville, TN 37203
3310 West End Avenue, Suite 700
Nashville, TN 37203
| Re: | Healthcare Realty Trust Incorporated |
Ladies and Gentlemen:
In our capacity as special securities counsel to Healthcare Realty Trust Incorporated, a
Maryland corporation (the “Company”), we have examined the Registration Statement on Form S-3
(Registration No. 333-150884) filed by the Company under the Securities Act of 1933, as amended,
the related Prospectus dated May 13, 2008 (the “Prospectus”), as supplemented by the Prospectus
Supplement dated January
11, 2011 (the “Prospectus Supplement”) as filed by the Company on January
11, 2011, relating to the offering of up to 3,000,000 shares of the common stock, par value $.01
per share, of the Company (the “Common Stock”). In this regard, we have examined and relied upon
such records, documents and other instruments as in our judgment are necessary or appropriate in
order to express the opinions hereinafter set forth and have assumed the genuineness of all
signatures, the authenticity of all documents submitted to us as originals, and the conformity to
original documents of all documents submitted to us as certified or photostatic copies.
Based upon the foregoing, we are of the opinion that the 3,000,000 shares of Common Stock
referred to in the Prospectus Supplement, to the extent actually issued and sold in the manner and
on the terms described in the Controlled Equity Offering Sales
Agreement, dated January
11, 2011,
between the Company and Cantor Fitzgerald & Co., the Sales Agreement, dated January 11, 2011,
between the Company and Credit Agricole Securities (USA) Inc., the Prospectus and the Prospectus
Supplement, will be duly and validly issued, fully paid and nonassessable shares of the Common
Stock of the Company.
We hereby consent to the filing of this opinion as an exhibit to the Company’s current report
on Form 8-K and further consent to the reference to us under the caption “Legal Matters” in the
Prospectus and the Prospectus Supplement. This consent is not to be construed as an admission that
we are a party whose consent is required to be filed with the Prospectus or the Prospectus
Supplement under the provisions of the Securities Act of 1933, as amended, or the rules and
regulations of the Securities and Exchange Commission promulgated thereunder.
Very truly yours,
/s/ Waller Lansden Dortch & Davis, LLP